Physician profile
Chandan Saw
NPI 1710925284
$4,859.24
in general payments reported to CMS, 2019-2025
12 companies · $752 in 2025
The $752 reported for 2025 was more than what 80% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $191 · 2020: $839 · 2021: $673 · 2022: $842 · 2023: $839 · 2024: $723 · 2025: $752.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,279 · Education: $34.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,279.40 |
| Education | $34.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,904.40 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,243.37 | 2020-2025 | Ofev, Jascayd, Spiriva Respimat |
| Astrazeneca Pharmaceuticals LP | $992.70 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Mylan Specialty L.P. | $163.57 | 2020-2023 | Yupelri |
| Insmed, INC. | $139.42 | 2019-2025 | Brinsupri, Arikayce |
| Philips North America LLC | $121.74 | 2021-2024 | (8874) Incourage |
| Abbvie INC. | $88.90 | 2022 | |
| Verona Pharma, INC. | $86.59 | 2025 | Ohtuvayre |
| Electromed, INC. | $37.60 | 2025 | Smartvest |
| Inspire Medical Systems, INC. | $32.14 | 2025 | Inspire |
| Baxter Healthcare | $31.58 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Lilly USA, LLC | $17.23 | 2025 | Zepbound |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chandan Saw listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.